Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Arthritis and Rheumatism|November 28, 2008
Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial respondersRogier M Thurlings, Koen Vos, Daniëlle M Gerlag, et al.
Joint Bone Spine|July 20, 2015
Intra-articular etanercept treatment in inflammatory arthritis: A randomized double-blind placebo-controlled proof of mechanism clinical trial validating TNF as a potential therapeutic target for local treatmentCaroline Aalbers, Danielle Gerlag, Koen Vos, et al.
Arthritis and Rheumatism|February 13, 2002
How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritisHenk Visser, Saskia le Cessie, Koen Vos, et al.
Arthritis and Rheumatism|March 1, 2007
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritisKoen Vos, Rogier M Thurlings, Carla A Wijbrandts, et al.
Annals of the Rheumatic Diseases|November 11, 2011
Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesisMaria J H Boumans, Rogier M Thurlings, Lorraine Yeo, et al.
Annals of the Rheumatic Diseases|November 10, 2012
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritisJacqueline E Paramarta, Leen De Rycke, Tanja F Heijda, et al.
Lupus Science & Medicine|August 22, 2025
Advancing treat-to-target in SLE: a pilot study using a clinical decision support systemAgner R Parra Sánchez, Koen Vos, Odile van Hall, et al.
Rheumatology (Oxford, England)|April 27, 2013
Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patientsMaria Boumans, Onno Teng, Rogier Thurlings, et al.
The Journal of Rheumatology|August 13, 2009
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centersBarry Bresnihan, Eliza Pontifex, Rogier M Thurlings, et al.
Arthritis and Rheumatism|August 20, 2010
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patientsRogier M Thurlings, Marie Boumans, Janneke Tekstra, et al.
Pageof 2